DE19882746T1 - Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering - Google Patents

Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering

Info

Publication number
DE19882746T1
DE19882746T1 DE19882746T DE19882746T DE19882746T1 DE 19882746 T1 DE19882746 T1 DE 19882746T1 DE 19882746 T DE19882746 T DE 19882746T DE 19882746 T DE19882746 T DE 19882746T DE 19882746 T1 DE19882746 T1 DE 19882746T1
Authority
DE
Germany
Prior art keywords
fibrin
enzyme
tissue engineering
mediated modification
mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19882746T
Other languages
English (en)
Inventor
Jeffery Hubbell
Jason C Schense
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology CalTech
Original Assignee
California Institute of Technology CalTech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute of Technology CalTech filed Critical California Institute of Technology CalTech
Publication of DE19882746T1 publication Critical patent/DE19882746T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00377—Fibrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
DE19882746T 1997-04-03 1998-04-02 Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering Withdrawn DE19882746T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4214397P 1997-04-03 1997-04-03
PCT/US1998/006617 WO1998043686A1 (en) 1997-04-03 1998-04-02 Enzyme-mediated modification of fibrin for tissue engineering
US09/057,052 US6331422B1 (en) 1997-04-03 1998-04-08 Enzyme-mediated modification of fibrin for tissue engineering

Publications (1)

Publication Number Publication Date
DE19882746T1 true DE19882746T1 (de) 2001-10-18

Family

ID=26718917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19882746T Withdrawn DE19882746T1 (de) 1997-04-03 1998-04-02 Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering

Country Status (7)

Country Link
US (2) US6331422B1 (de)
EP (1) EP1124590B1 (de)
AU (1) AU7245598A (de)
CA (1) CA2307954C (de)
DE (1) DE19882746T1 (de)
GB (1) GB2348426B (de)
WO (1) WO1998043686A1 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485440B2 (en) 1995-09-27 2009-02-03 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6894022B1 (en) * 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7601685B2 (en) * 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7241730B2 (en) 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
DE19945487A1 (de) * 1999-09-22 2001-03-29 Henkel Kgaa Verfahren zur Restrukturierung keratinischer Fasern
GB0011356D0 (en) * 2000-05-12 2000-06-28 Univ Nottingham Trent Medical implant materials
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
US6506365B1 (en) 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
ES2321068T3 (es) 2001-04-25 2009-06-02 Eidgenossische Technische Hochschule Zurich Matrices de suministro de farmacos para mejorar la curacion de heridas.
NL1017994C2 (nl) * 2001-05-04 2002-11-05 Tno Hechting van vlees- en visproducten.
JP2002369877A (ja) * 2001-06-14 2002-12-24 Japan Science & Technology Corp 神経再建生体材料およびその製造方法
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
US8815793B2 (en) 2001-07-20 2014-08-26 Northwestern University Polymeric compositions and related methods of use
US7858679B2 (en) 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
US7618937B2 (en) 2001-07-20 2009-11-17 Northwestern University Peptidomimetic polymers for antifouling surfaces
JP2003126125A (ja) * 2001-10-24 2003-05-07 Katsuko Sakai 人工血管及びその製造方法
FI20012082A0 (fi) 2001-10-26 2001-10-26 Paeivi Liesi Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
CA2468187A1 (en) * 2001-11-28 2003-06-05 Becton, Dickinson And Company Peptides with growth inhibitory action
EP1864681A1 (de) 2001-12-18 2007-12-12 Eidgenössische Technische Hochschule Zürich Wachstumsfaktormodifizierte Proteinmatrizes zur Geweberekonstruktion
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
AU2003215280A1 (en) 2002-02-15 2003-09-09 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US8911831B2 (en) 2002-07-19 2014-12-16 Northwestern University Surface independent, surface-modifying, multifunctional coatings and applications thereof
WO2004016167A1 (en) * 2002-08-16 2004-02-26 The General Hospital Corporation Non-invasive functional imaging of peripheral nervous system activation in humans and animals
US20060140914A1 (en) * 2002-10-31 2006-06-29 The General Hospital Corporation Repairing or replacing tissues or organs
WO2004042068A2 (en) * 2002-10-31 2004-05-21 Northwestern University Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20080050812A1 (en) * 2003-05-30 2008-02-28 Cox James W Micropositioning Cells For Tissue Engineering
CA2527728A1 (en) 2003-05-30 2004-12-16 Board Of Regents, The University Of Texas System Micropositioning cells for tissue engineering
KR20060032140A (ko) * 2003-05-30 2006-04-14 센토코 인코포레이티드 트랜스글루타미나아제를 이용한 신규 에리트로포이에틴접합체의 형성
US7338517B2 (en) 2003-06-04 2008-03-04 University Of South Carolina Tissue scaffold having aligned fibrils and artificial tissue comprising the same
CN102225964A (zh) 2003-12-05 2011-10-26 西北大学 自组装的肽两亲物和用于生长因子传递的相关方法
WO2005072764A2 (en) * 2004-01-16 2005-08-11 Novocell, Inc. Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
ES2293753B1 (es) * 2004-04-28 2009-03-16 Lipotec, S.A. Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
WO2006050213A2 (en) * 2004-10-29 2006-05-11 Michalow Alexander E Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway
KR101206345B1 (ko) 2004-12-10 2012-12-06 스트라우만 홀딩 에이쥐 신규한 단백질 배합물
MX2007007732A (es) * 2004-12-22 2007-10-08 Kuros Biosurgery Ag Hidrogeles peg con grupos funcionales para la reaccion de adicion tipo michael con biofactores incorporados con el factor xiiia.
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
BRPI0606409A2 (pt) 2005-01-06 2009-06-23 Kuros Biosurgery Ag matrizes suplementadas para o reparo de fraturas ósseas
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (de) 2005-09-19 2015-01-07 Histogenics Corporation Zellunterstützende matrix mit eng definierter, gleichmässig senkrecht und nicht zufällig organisierter porosität und porendichte und verfahren zur herstellung davon
US7732539B2 (en) 2006-02-16 2010-06-08 National Science Foundation Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
US8865869B2 (en) * 2006-03-20 2014-10-21 Worcester Polytechnic Institute Collagen and fibrin microthreads in a discrete thread model of in vitro ACL scaffold regeneration
EP2064251B1 (de) 2006-08-04 2017-10-25 Kensey Nash Corporation Biomimetische verbindungen und syntheseverfahren dafür
US8563117B2 (en) 2006-08-04 2013-10-22 Phillip B. Messersmith Biomimetic modular adhesive complex: materials, methods and applications therefore
EP2111239B1 (de) 2006-12-15 2013-03-06 Lifebond Ltd. Hämostatische gelatin-transglutaminase-verbände und dichtungsstoffe
US8673286B2 (en) 2007-04-09 2014-03-18 Northwestern University DOPA-functionalized, branched, poly(aklylene oxide) adhesives
US8383092B2 (en) * 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
DK2136850T3 (da) 2007-04-13 2012-04-10 Kuros Biosurgery Ag Polymervævforsegling
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
JP4966084B2 (ja) 2007-04-25 2012-07-04 エスアイアイ・プリンテック株式会社 インクジェットヘッドの駆動方法、インクジェットヘッドおよびインクジェット記録装置
WO2009033774A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a laminin nonapeptide as a therapeutic agent
JP2011511651A (ja) * 2007-10-12 2011-04-14 クロス・バイオサージェリー・アクチェンゲゼルシャフト 組織増強のための注入可能な放射線不透過組成物
JP2012512812A (ja) 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト フィブリンフォームに組込まれたｐｄｇｆ融合タンパク質
CA2721477A1 (en) * 2008-04-18 2009-12-03 Kuros Biosurgery Ag Dispensing device, kit containing the device, and method of operating the device
CN102124058B (zh) 2008-06-18 2014-05-28 生命连结有限公司 改进的交联组合物
EP2419116A1 (de) 2009-04-13 2012-02-22 North Western University Neue peptidbasierte gerüste für knorpelregenerierung und anwendungsverfahren dafür
US20100316764A1 (en) * 2009-06-10 2010-12-16 Engrain, LLC Flour supplement compositions and methods for preparing wheat flour
AU2010334412B2 (en) 2009-12-22 2016-02-04 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
WO2011100460A2 (en) * 2010-02-11 2011-08-18 Ecole Polytechnique Federale De Lausanne Ccr7 ligand delivery and co-delivery in immunotherapy
ITPD20100155A1 (it) 2010-05-19 2011-11-20 Univ Padova Metodo per la preparazione di coniugati mediante transglutaminasi
AU2011287215B2 (en) 2010-08-05 2015-09-10 Lifebond Ltd. Dry composition wound dressings and adhesives
US9320826B2 (en) 2010-11-09 2016-04-26 Kensey Nash Corporation Adhesive compounds and methods use for hernia repair
EP2686027B1 (de) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmazeutische formulierung zur verwendung für die wirbelsäulenfusion
US20150104427A1 (en) * 2011-11-10 2015-04-16 The Regents Of The University Of California Enzyme-assisted spatial decoration of biomaterials
US9879062B2 (en) 2012-07-03 2018-01-30 Ecole Polytechnique Federale De Lausanne Protein-binding peptide isolated from placenta growth factor
US9540428B2 (en) 2012-07-03 2017-01-10 Ecole Polytechnique Federale De Lausanne (Epfl) Extracellular matrix heparin-binding domains
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10322206B2 (en) 2016-03-29 2019-06-18 Worcester Polytechnic Institute Compositions and methods for wound healing
EP3453722A1 (de) * 2017-09-06 2019-03-13 Julius-Maximilians-Universität Würzburg Pharmazeutika und vorrichtungen für kovalente immobilisierung an der extrazellulären matrix durch transglutaminase
EP3710466A2 (de) 2017-11-13 2020-09-23 The University of Chicago Verfahren und zusammensetzungen zur behandlung von wunden
EP3569614A1 (de) * 2018-05-18 2019-11-20 Julius-Maximilians-Universität Würzburg Verbindungen und verfahren zur immobilisierung von myostatin-inhibitoren auf der extrazellulären matrix durch transglutaminase
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
ATE185376T1 (de) 1987-07-06 1999-10-15 Biopool Int Inc Verfahren zur messung von gewebeplasminogenaktivator, antithrombin-iii und lösliches fibrin
EP0325639A4 (en) * 1987-07-07 1990-10-24 Cytrx Biopool Ltd. Fibrin-binding compound and method
US5504001A (en) * 1987-11-25 1996-04-02 Zymogenetics, Inc. Hybrid plasminogen activator
US5100668A (en) 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
EP0406357B1 (de) * 1988-11-09 1998-01-07 Protein Polymer Technologies, Inc. Funktionelles, durch ein rekombinantes verfahren hergestelltes synthetisches proteinpolymer
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
US5428014A (en) * 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5773577A (en) * 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5693341A (en) 1995-03-16 1997-12-02 Collagen Corporation Affinity bound collagen matrices for the delivery of biologically active agents
US5561982A (en) 1995-05-02 1996-10-08 Universal Vortex, Inc. Method for energy separation and utilization in a vortex tube which operates with pressure not exceeding atmospheric pressure
US5958874A (en) * 1998-02-18 1999-09-28 The Research Foundation Of State University Of New York Recombinant fibronectin-based extracellular matrix for wound healing

Also Published As

Publication number Publication date
US6607740B1 (en) 2003-08-19
EP1124590A1 (de) 2001-08-22
GB2348426A (en) 2000-10-04
CA2307954C (en) 2010-07-13
GB0009882D0 (en) 2000-06-07
WO1998043686A1 (en) 1998-10-08
GB2348426B (en) 2001-06-27
AU7245598A (en) 1998-10-22
EP1124590B1 (de) 2009-06-17
CA2307954A1 (en) 1998-10-08
US6331422B1 (en) 2001-12-18

Similar Documents

Publication Publication Date Title
DE19882746T1 (de) Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering
DE69734845D1 (de) Zusammenbau von chirurgischen Klingen
DE69817594D1 (de) Fibrinschwamm
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69834967D1 (de) System für Mapping und Ablation von Gewebe
DE59804782D1 (de) Gitter für die Fixierung von Knochenteilen oder für die Überbrückung von Knochenfehlstellen
DE69800637D1 (de) Auswahl von Grenzwerten für Patientenüberwachungssysteme
DE69634987D1 (de) Biomedizinische elektroden für mehrere anwendungsgebiete
DK1011699T3 (da) Galactosidase-modificeret submucosavæv
DE69924477D1 (de) Wiederlösbarer spreizanker für chirurgischen nähfaden
FI960469A0 (fi) DNA:ta sekvenssoivia entsyymejä
DE69827132T8 (de) Anordnung zur anwendung von fibrin-kleber
DE69726479D1 (de) Selektive Verfeinerung von Gitternetzen
PT914103E (pt) Tratamento de uma hemoglobinopatia
DE69926911D1 (de) Hämostatische kollagenfasern
KR970702929A (ko) 건조 프로트롬빈의 경시적 검정 방법(dry prothrombin time assay)
DE69913553D1 (de) Konfigurierung von systemeinheiten
MA26668A1 (fr) ACTIVATEURS DE hPPARy ET hPPARa
DE59508908D1 (de) Elektrochemischer Enzymbiosensor
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
DE59803282D1 (de) Anordnung von schaltern
DE69507420D1 (de) Elektrochemisches Bohren von Substraten
DE69706434D1 (de) Enzymatisches oxidationsverfahren
NO20002659L (no) Trombinreseptorantagonister
DE69829990D1 (de) Vorrichtung für das micromechanische schalten von signalen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C07K 19/00 AFI20051017BHDE

8139 Disposal/non-payment of the annual fee